Amazon’s Cash Engine Strengthens, But AI Spending Raises the Stakes
Amazon’s operating cash flow is surging, yet a $220 billion investment plan complicates the bullish case for AMZN shares.

Every Stocks story we have published, newest first.
83 stories in the last 24 hours
Updated 12:55 PM (Times shown in New York time (ET))
Page 24 of 25 · 581 stories
Amazon’s operating cash flow is surging, yet a $220 billion investment plan complicates the bullish case for AMZN shares.

The new Ho Chi Minh City subsidiary creates a sales and distribution foothold, but Tesla has not disclosed launch timing or local production plans.

Lowe’s offers thinner sales momentum but stronger payout coverage as weak housing demand keeps pressure on both retailers.

AMD brings faster growth potential, but ASML’s monopoly on advanced lithography offers investors a sturdier way to play AI infrastructure.

AST SpaceMobile has cash, contracts and satellites, but its valuation already assumes a near-flawless commercial rollout.

GRMN has slipped from its August peak, but its three-month gain still outpaces technology stocks as earnings momentum strengthens.

The Danish drugmaker is pairing a consumer-facing rebrand with a culture reset as Eli Lilly widens its lead in obesity medicines.

Eaton’s power-infrastructure backlog contrasts with Rivian’s costly R2 ramp, making the choice hinge on certainty versus upside.

The five-company list spans retail, healthcare, entertainment and mortgage assets, with yields ranging from about 4% to 14%.

The recommendation strengthens Kirill Klip’s position as shareholders prepare to vote on a full board overhaul proposed by Eucalyptus Resources.

Investors briefly questioned the spending engine behind the AI boom after Anthropic’s CEO urged companies to slow model development.

A binding power contract with TVA would validate NuScale’s model, while another delay could expose the stock’s thin commercial foundation.

The insurance broker will leave Nasdaq as new owners pair patient capital with an aggressive push into artificial intelligence.

The GameStop and Uber chiefs made discretionary purchases, but the businesses they are betting on face very different investor tests.

A weekend warning from AI leaders jolted semiconductor shares while investors rotated toward cybersecurity and less crowded trades.

Novo Nordisk is shortening its public name as it prepares investors for a sharper strategic push in the obesity-drug race.

Three midstream C-corps combine fee-based cash flow, rising dividends and simpler 1099 tax reporting for income investors.

ISEMBYLD approval moves Scholar Rock into commercialization after a manufacturing setback delayed its first attempt last year.

JPMorgan cut MARA to Underweight and lowered its target, reviving concerns about weak revenue and the payoff from its AI pivot.

Applied Materials fell alongside major chip names after AI leaders urged a slower development pace, reviving questions about future infrastructure demand.

A Finnish power contract gives Alphabet more than clean electricity: it buys time, capacity and certainty for an expensive AI buildout.

Citi says AstraZeneca’s breast cancer setback is manageable as a narrower Etcamah launch and wider pipeline support its valuation.

Micron’s 5.2% drop reflects a broader retreat from AI-linked semiconductors ahead of its September 30 earnings report.

The infrastructure provider’s huge backlog is colliding with new questions about AI’s pace, economics and capital intensity.
